Abeona Therapeutics (NASDAQ:ABEO) just reported results for the first quarter of 2024.Abeona Therapeutics reported earnings ...

Recently in our inbox, from Nigerian designer Samiat Salami of ready-to-wear fashion and homewares line Oya Abeó: a ...

CLEVELAND — CLEVELAND — Abeona Therapeutics Inc. (ABEO) on Wednesday reported a loss of $31.6 million in its first quarter. On a per-share basis, the Cleveland-based company said it had a loss of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

For the complete transcript of the earnings call, please refer to the full earnings call transcript. Abeona Therapeutics Inc ( NASDAQ:ABEO) successfully raised $75 million in gross proceeds from an ...

On April 22, 2024, Abeona Therapeutics, Inc. (NASDAQ:ABEO) announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) in response to the Biologics License ...

The Law Offices of Frank R. Cruz announces an investigation of Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ...

Cantor Fitzgerald raised the price target for the Abeona Therapeutics Inc (NASDAQ:ABEO) stock from “a Neutral” to “an Overweight”. The rating was released on November 11, 2020, according to finviz.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered ...